Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01394978 · ClinicalTrials.gov registry record · NA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 444
- Enrollment target
NCT01394978 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 444 participants.
The verdict
NCT01394978, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 444 participants
- Enrollment target
Study Summary
The purpose of this post approval study is to further characterize the safety profile of the ProGEL™ Pleural Air Leak Sealant in commercial use, with specific reference to long-term safety over 90 days of follow-up.
Interventions
- OTHER Control
- DEVICE ProGEL Pleural Air Leak Sealant with standard surgical closure
- DEVICE ProGEL Pleural Air Leak Sealant without standard surgical closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01394978
The ClinicalTrials.gov registry entry for NCT01394978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 444 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT01394978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01394978 about?
NCT01394978 is a clinical study titled "NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study". The purpose of this post approval study is to further characterize the safety profile of the ProGEL™ Pleural Air Leak Sealant in commercial use, with specific reference to long-term safety over 90 days of follow-up.
What is the current status of trial NCT01394978?
This trial is currently completed. It is a NA study. The enrollment target is 444 participants. The study started on 2011-06. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01394978?
The interventions under investigation include: Control (OTHER), ProGEL Pleural Air Leak Sealant with standard surgical closure (DEVICE), ProGEL Pleural Air Leak Sealant without standard surgical closure (DEVICE).
Who is sponsoring clinical trial NCT01394978?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.